Company
AllinBio
A precision medicine approach to treating chronic inflammatory disease
Also known as AllIn Bio
- Status
- Operatingas of 2026-09-18
Claim, correct or request removal
Record updated 28 September 2026
About
ALLInBio is developing a precision immunology approach that allows the selection and early treatment of "at-risk" patient populations that are genetically predisposed to rapidly progress and develop severe disease. Through this approach, we will shift patient care in chronic inflammation from treating symptoms to addressing the root cause of disease.
Loading relationship preview